← Leaderboards
Paco S Herson
University Of Colorado Denver
$11,691,083
Attributed
$17,714,767
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,714,767 · 13
By mechanism
R01$15,148,445 · 9
RF1$1,693,719 · 1
R21$774,392 · 2
UE5$98,211 · 1
Top collaborators
- K. Ulrich Bayer10 shared
- Nidia Quillinan9 shared
- Eric Peter Schmidt8 shared
- John P Adelman4 shared
- Russell Lonser2 shared
- David Wm Marr2 shared
- Keith B Neeves2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- K. Ulrich Bayer$14,252,411
- James P Grigsby$7,318,061
- Joseph Alan Hippensteel$1,120,080
- Edward L Melanson$6,892,130
- Steven K Nordeen$2,823,239
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventLearningMemoryBrainHeart ArrestResponseMediatingNeuronsSynaptic PlasticityHippocampus (Brain)United StatesCell DeathInjuryIn VivoLong-Term PotentiationNeuroprotectionCause Of DeathPharmaceutical PreparationsPhysiologicalRegulationCardiopulmonary ResuscitationIschemiaCerebral IschemiaNeurological Outcome
Grant awards (49)
Vascular mechanisms of sepsis-induced cognitive dysfunction$696,071
R01 · FY2025 · HL · contact PI
New approach to sustained neuroprotection and enhanced recovery following acute ischemic stroke$564,573
R01 · FY2025 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$349,875
R01 · FY2025 · NS
Ohio State University Wexner Medical Center R25 Neurological Surgery Resident Research Training Program$1
UE5 · FY2025 · NS · contact PI
Vascular mechanisms of sepsis-induced cognitive dysfunction$682,150
R01 · FY2024 · HL · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$377,088
R01 · FY2024 · NS
Sex differences in brain injury following pediatric cardiac arrest$345,496
R01 · FY2024 · NS · contact PI
Ohio State University Wexner Medical Center R25 Neurological Surgery Resident Research Training Program$98,210
UE5 · FY2024 · NS · contact PI
Vascular mechanisms of sepsis-induced cognitive dysfunction$726,968
R01 · FY2023 · HL · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2023 · NS
Sex differences in brain injury following pediatric cardiac arrest$356,182
R01 · FY2023 · NS · contact PI
New approach to sustained neuroprotection and enhanced recovery following acute ischemic stroke$1,693,719
RF1 · FY2022 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2022 · NS
Sex differences in brain injury following pediatric cardiac arrest$356,182
R01 · FY2022 · NS · contact PI
Sex differences in brain injury following pediatric cardiac arrest$74,107
R01 · FY2022 · NS · contact PI
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention$388,750
R01 · FY2021 · NS
Sex differences in brain injury following pediatric cardiac arrest$360,851
R01 · FY2021 · NS · contact PI
Sex differences in brain injury following pediatric cardiac arrest$94,933
R01 · FY2021 · NS · contact PI
Sex differences in brain injury following pediatric cardiac arrest$65,850
R01 · FY2021 · NS · contact PI
Sex differences in brain injury following pediatric cardiac arrest$8,257
R01 · FY2021 · NS · contact PI
Sex differences in brain injury following pediatric cardiac arrest$455,784
R01 · FY2020 · NS · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$438,956
R01 · FY2020 · GM
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia$340,156
R01 · FY2020 · NS · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$441,651
R01 · FY2019 · GM
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia$340,156
R01 · FY2019 · NS · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$139,824
R01 · FY2019 · GM
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$446,852
R01 · FY2018 · GM
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia$340,156
R01 · FY2018 · NS · contact PI
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy$480,646
R01 · FY2017 · GM
CaMKII in global cerebral ischemia$414,386
R01 · FY2017 · NS · contact PI
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia$340,156
R01 · FY2017 · NS · contact PI
CaMKII in global cerebral ischemia$414,386
R01 · FY2016 · NS · contact PI
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia$340,156
R01 · FY2016 · NS · contact PI
CaMKII in global cerebral ischemia$414,164
R01 · FY2015 · NS · contact PI
CaMKII in global cerebral ischemia$408,703
R01 · FY2014 · NS · contact PI
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut$170,128
R21 · FY2014 · NS
CaMKII in global cerebral ischemia$411,499
R01 · FY2013 · NS · contact PI
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut$202,200
R21 · FY2013 · NS
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia$325,973
R01 · FY2012 · NS
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia$326,990
R01 · FY2011 · NS
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia$334,633
R01 · FY2010 · NS
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia$333,507
R01 · FY2010 · NS · contact PI
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia$86,240
R01 · FY2010 · NS · contact PI
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia$338,013
R01 · FY2009 · NS
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia$336,875
R01 · FY2009 · NS · contact PI
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia$336,875
R01 · FY2008 · NS · contact PI
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia$336,875
R01 · FY2007 · NS · contact PI
Sex differences in Purkinje cell sensitivity to ischemia$173,314
R21 · FY2006 · NS · contact PI
Sex differences in Purkinje cell sensitivity to ischemia$228,750
R21 · FY2005 · NS